Pacific Biosciences of California Inc (NASDAQ:PACB) currently has a daily average trading volume of 11.25M but it saw 8941558 shares traded in last market. With a market cap of 350.54M USD, the company’s current market price of $1.28 came falling about -2.29 while comparing to the previous closing price of $1.31. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.42 and as low as $1.16. In the recent trading on the day, stock has struck highest price mark of $1.28 while lowest mark touched by it was $1.3661.
Taking a look at 20-day trading activity of Pacific Biosciences of California Inc (PACB) gives us an average price of $1.4928, while its current price level is -71.04% below from 52-week high level whereas it is 10.34% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.6270 while that of 200 days or SMA-200 reads an average of $1.7474. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.76% during that period while stretching the period over a month that increases to 12.43%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 39.23 which implies that the stock is in neutral territory.
Over the week, PACB’s stock price is moving -4.48% down while it is -3.76% when we observe its performance for the past one month. Year-to-date it is -30.05% down and over the past year, the stock is showing a downside performance of -71.11%.
Currently, Pacific Biosciences of California Inc’s total number of outstanding shares is 273.86M with 9.29% of that held by the insiders while 85.09% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -26.15% and return on equity (ROE) at -51.05%. Stock’s beta reads 1.98. Stock has a price to book (P/B) ratio of 0.77 while price to sale or P/S ratio amounts to 2.28. Its return on asset (ROA) is -20.52% on average.
